Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.
Phenylephrine was granted FDA approval in 1939.
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation is used to treat hemorrhoids. Off-label uses include priapism and induction of local vasoconstriction.
Aarhus University Hospital, Aarhus, Denmark
Clements University Hospital at Dallas, Dallas, Texas, United States
University of Alberta, Edmonton, Alberta, Canada
London Health Sciences Centre, London, Ontario, Canada
Yasmin Ibrahim, Cairo, Egypt
Beijing Tiantan Hospital, Capital Medical University, Beijing, China
University of Alberta, Edmonton, Alberta, Canada
University of British Columbia - Okanagan, Kelowna, British Columbia, Canada
Medical University of Vienna, Vienna, Austria
Cardiac Catheterization Lab,Stanford University Medical Center, Stanford, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.